Back

Evaluation of concordance and association with clinical outcomes across eGFR values calculated with eight different formulas in a large cohort of european patients with atrial fibrillation.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Management of comorbidities and outcomes in atrial fibrillation (2) Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Giuseppe Boriani

Modena Polyclinic Modena University Hospital, Modena (Italy)

7 More presentations in this session

Presentation thumbnail
Effect of the longitudinal change in anemia status on clinical outcomes for patients with nonvalvular atrial fibrillation: analysis from the Hokuriku-Plus AF registry
Doctor T. Tsuda (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Implications of renal function on adverse clinical events in patients with atrial fibrillation: a comparative analysis of VKA and NOAC therapy - Insights from the GLORIA-AF Registry Phase III
Doctor Y. Chen (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Risk of atrial fibrillation recurrence after new-onset transient episode during ST-elevation myocardial infarction
Doctor M. Demidova (Lund, SE) Professor P. Platonov (Lund, SE)
Abstract Slides Video
Presentation thumbnail
Adherence to the Atrial Fibrillation Better Care (ABC) pathway and outcomes in patients with chronic kidney disease: A report from the APHRS-AF registry.
Doctor T. Bucci (Perugia, IT)
Abstract Slides Video
Presentation thumbnail
Predictors of discordance in estimating the presence of chronic kidney disease among patients with atrial fibrillation and impact on prescription of anticoagulants and cardiovascular outcomes
Doctor M. Mantovani (Modena, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Management of comorbidities and outcomes in atrial fibrillation (2)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Predictors of discordance in estimating the presence of chronic kidney disease among patients with atrial fibrillation and impact on prescription of anticoagulants and cardiovascular outcomes
thumbnail
Congress Presentation
Relative and absolute benefit of dapagliflozin using different eGFR estimates: insights from DAPA-HF trial
thumbnail
Congress Presentation
Clinical impact of kidney function in patients with atrial fibrillation receiving oral anticoagulants

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources